ARCHIVES

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

A Conversation With Daniel Masys: Acronym “CABIG” Could Be Eliminated

January 6, 2012

CCIRC Loses Policy Making, Protocol Review

September 26, 1975

Two New Communications Contracts Approved

October 18, 1985

ASCO Conquer Cancer Foundation Awards $6 Million To Researchers

April 22, 2011

Pharmacogenomics May Lead To Individualized Treatment

June 25, 2004

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987